Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death

Experimental Neurology

Volumn 237, Issue 2, 2012, Pages 346-354

  McKiernan, Ross C ^a   Jimenez Mateos, Eva M ^a   Sano, Takanori ^a   Bray, Isabella ^a   Stallings, Raymond L ^a,b   Simon, Roger P ^c   Henshall, David C ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Dicer; Epigenetics; Hippocampus; Status epilepticus; Temporal lobe epilepsy

Indexed keywords

ANTAGOMIR; KAINIC ACID; MICRORNA; MICRORNA 184; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPILEPSY; EPILEPTIC STATE; EXPLORATORY BEHAVIOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIPPOCAMPAL CA3 REGION; IN SITU HYBRIDIZATION; IN VIVO STUDY; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SOCIAL BEHAVIOR; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL DEATH; CONVULSANTS; ELECTROENCEPHALOGRAPHY; EPILEPSY; GENE EXPRESSION PROFILING; HIPPOCAMPUS; IN SITU HYBRIDIZATION; KAINIC ACID; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; NEURONS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEIZURES; UP-REGULATION;

EID: 84864796082     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.06.029     Document Type: Article

References (55)

1. Aronica E., Fluiter K., Iyer A., Zurolo E., Vreijling J., van Vliet E.A., Baayen J.C., Gorter J.A. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur. J. Neurosci. 2010, 31:1100-1107.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
4. Borges K., Gearing M., McDermott D.L., Smith A.B., Almonte A.G., Wainer B.H., Dingledine R. Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp. Neurol. 2003, 182:21-34.
5. Bozzi Y., Dunleavy M., Henshall D.C. Cell signaling underlying epileptic behavior. Front. Behav. Neurosci. 2011, 5:45.
6. Bray I., Bryan K., Prenter S., Buckley P.G., Foley N.H., Murphy D.M., Alcock L., Mestdagh P., Vandesompele J., Speleman F., London W.B., McGrady P.W., Higgins D.G., O'Meara A., O'Sullivan M., Stallings R.L. Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival. PLoS One 2009, 4:e7850.
7. Cheloufi S., Dos Santos C.O., Chong M.M., Hannon G.J. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 2010, 465:584-589.
8. Chen J., Simon R. Ischemic tolerance in the brain. Neurology 1997, 48:306-311.
9. Chi S.W., Zang J.B., Mele A., Darnell R.B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009, 460:479-486.
10. Cifuentes D., Xue H., Taylor D.W., Patnode H., Mishima Y., Cheloufi S., Ma E., Mane S., Hannon G.J., Lawson N.D., Wolfe S.A., Giraldez A.J. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 2010, 328:1694-1698.
11. Clifford J.J., Usiello A., Vallone D., Kinsella A., Borrelli E., Waddington J.L. Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor. Neuropharmacology 2000, 39:382-390.
12. Davis T.H., Cuellar T.L., Koch S.M., Barker A.J., Harfe B.D., McManus M.T., Ullian E.M. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 2008, 28:4322-4330.
13. Dharap A., Vemuganti R. Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J. Neurochem. 2010, 113:1685-1691.
14. Dirnagl U., Simon R.P., Hallenbeck J.M. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003, 26:248-254.
15. Eacker S.M., Dawson T.M., Dawson V.L. Understanding microRNAs in neurodegeneration. Nat. Rev. Neurosci. 2009, 10:837-841.
16. Eacker S.M., Keuss M.J., Berezikov E., Dawson V.L., Dawson T.M. Neuronal activity regulates hippocampal miRNA expression. PLoS One 2011, 6:e25068.
17. Fiore R., Siegel G., Schratt G. MicroRNA function in neuronal development, plasticity and disease. Biochim. Biophys. Acta 2008, 1779:471-478.
18. Foley N.H., Bray I.M., Tivnan A., Bryan K., Murphy D.M., Buckley P.G., Ryan J., O'Meara A., O'Sullivan M., Stallings R.L. MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2. Mol. Cancer 2010, 9:83.
19. Gidday J.M. Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 2006, 7:437-448.
20. Harvey B.D., Sloviter R.S. Hippocampal granule cell activity and c-Fos expression during spontaneous seizures in awake, chronically epileptic, pilocarpine-treated rats: implications for hippocampal epileptogenesis. J. Comp. Neurol. 2005, 488:442-463.
21. Hatazaki S., Bellver-Estelles C., Jimenez-Mateos E.M., Meller R., Bonner C., Murphy N., Matsushima S., Taki W., Prehn J.H., Simon R.P., Henshall D.C. Microarray profile of seizure damage-refractory hippocampal CA3 in a mouse model of epileptic preconditioning. Neuroscience 2007, 150:467-477.
22. Hebert S.S., De Strooper B. Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 2009, 32:199-206.
23. Hers I., Vincent E.E., Tavare J.M. Akt signalling in health and disease. Cell. Signal. 2011, 23:1515-1527.
24. Hu K., Zhang C., Long L., Long X., Feng L., Li Y., Xiao B. Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus. Neurosci. Lett. 2011, 488:252-257.
25. Jimenez-Mateos E.M., Henshall D.C. Seizure preconditioning and epileptic tolerance: models and mechanisms. Int. J. Physiol. Pathophysiol. Pharmacol. 2009, 1:180-191.
26. Jimenez-Mateos E.M., Hatazaki S., Johnson M.B., Bellver-Estelles C., Mouri G., Bonner C., Prehn J.H., Meller R., Simon R.P., Henshall D.C. Hippocampal transcriptome after status epilepticus in mice rendered seizure damage-tolerant by epileptic preconditioning features suppressed calcium and neuronal excitability pathways. Neurobiol. Dis. 2008, 32:442-453.
27. Jimenez-Mateos E.M., Mouri G., Conroy R.M., Henshall D.C. Epileptic tolerance is associated with enduring neuroprotection and uncoupling of the relationship between CA3 damage, neuropeptide Y rearrangement and spontaneous seizures following intra-amygdala kainic acid-induced status epilepticus in mice. Neuroscience 2010, 171:556-565.
28. Jimenez-Mateos E.M., Bray I., Sanz-Rodriguez A., Engel T., McKiernan R., Mouri G., Tanaka K., Sano T., Saugstad J.A., Simon R.P., Stallings R.L., Henshall D.C. MicroRNA expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132. Am. J. Pathol. 2011, 179:2519-2532.
29. Jimenez-Mateos E.M., Engel T., Merino-Serrais P., McKiernan R.C., Tanaka K., Mouri G., Sano T., O'Tuathaigh C., Waddington J.L., Prenter S., Delanty N., Farrell M.A., O'Brien D.F., Conroy R.M., Stallings R.L., Defelipe J., Henshall D.C. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat. Med. 2012, 18:1087-1094.
30. Kelly T.K., De Carvalho D.D., Jones P.A. Epigenetic modifications as therapeutic targets. Nat. Biotechnol. 2010, 28:1069-1078.
31. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
32. Lee S.T., Chu K., Jung K.H., Yoon H.J., Jeon D., Kang K.M., Park K.H., Bae E.K., Kim M., Lee S.K., Roh J.K. MicroRNAs induced during ischemic preconditioning. Stroke 2010, 41:1646-1651.
33. Liu C., Teng Z.Q., Santistevan N.J., Szulwach K.E., Guo W., Jin P., Zhao X. Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. Cell Stem Cell 2010, 6:433-444.
34. Liu D.Z., Tian Y., Ander B.P., Xu H., Stamova B.S., Zhan X., Turner R.J., Jickling G., Sharp F.R. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab. 2010, 30:92-101.
35. Lusardi T.A., Farr C.D., Faulkner C.L., Pignataro G., Yang T., Lan J., Simon R.P., Saugstad J.A. Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J. Cereb. Blood Flow Metab. 2010, 30:744-756.
36. Lusardi T.A., Thompson S.J., Macdonald I.C., Lan J.Q., Theofilas P., Saugstad J.A. Effect of (S)-3,5-DHPG on microRNA expression in mouse brain. Exp. Neurol. 2012, 235:497-507.
37. Maysami S., Lan J.Q., Minami M., Simon R.P. Proliferating progenitor cells: a required cellular element for induction of ischemic tolerance in the brain. J. Cereb. Blood Flow Metab. 2008, 28:1104-1113.
38. McKiernan, R. C., Jimenez-Mateos, E. M., Bray, I., Engel, T., Sano, T., Delanty, N., Farrell, M. A., O'Brien, D. F., Meller, R., Simon, R. P., Stallings, R. L., and Henshall, D. C., in press. Reduced mature microRNA levels in association with Dicer loss in human temporal lobe epilepsy with hippocampal sclerosis. PLoS One 7, e35921.
39. Miller-Delaney S.F., Das S., Sano T., Jimenez-Mateos E.M., Bryan K., Buckley P.G., Stallings R.L., Henshall D.C. Differential DNA methylation patterns define status epilepticus and epileptic tolerance. J. Neurosci. 2012, 32:1577-1588.
40. Nomura T., Kimura M., Horii T., Morita S., Soejima H., Kudo S., Hatada I. MeCP2-dependent repression of an imprinted miR-184 released by depolarization. Hum. Mol. Genet. 2008, 17:1192-1199.
41. Nudelman A.S., DiRocco D.P., Lambert T.J., Garelick M.G., Le J., Nathanson N.M., Storm D.R. Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus 2010, 20:492-498.
42. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2001, Elsevier, San Diego, CA. second edition.
43. Peters L., Meister G. Argonaute proteins: mediators of RNA silencing. Mol. Cell 2007, 26:611-623.
44. Pichardo-Casas I., Goff L.A., Swerdel M.R., Athie A., Davila J., Ramos-Brossier M., Lapid-Volosin M., Friedman W.J., Hart R.P., Vaca L. Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulation. Brain Res. 2012, 1436:20-33.
45. Sano T., Reynolds J.P., Jimenez-Mateos E.M., Matsushima S., Taki W., Henshall D.C. MicroRNA-34a upregulation during seizure-induced neuronal death. Cell Death Dis. 2012, 3:e287.
46. Saugstad J.A. MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. J. Cereb. Blood Flow Metab. 2010, 30:1564-1576.
47. Schaefer A., O'Carroll D., Tan C.L., Hillman D., Sugimori M., Llinas R., Greengard P. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 2007, 204:1553-1558.
48. Schmued L.C., Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 2000, 874:123-130.
49. Song Y.J., Tian X.B., Zhang S., Zhang Y.X., Li X., Li D., Cheng Y., Zhang J.N., Kang C.S., Zhao W. Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b. Brain Res. 2011, 1387:134-140.
50. Stapels M., Piper C., Yang T., Li M., Stowell C., Xiong Z.G., Saugstad J., Simon R.P., Geromanos S., Langridge J., Lan J.Q., Zhou A. Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance. Sci. Signal. 2010, 3:ra15.
51. Stenzel-Poore M.P., Stevens S.L., Xiong Z., Lessov N.S., Harrington C.A., Mori M., Meller R., Rosenzweig H.L., Tobar E., Shaw T.E., Chu X., Simon R.P. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 2003, 362:1028-1037.
52. Stenzel-Poore M.P., Stevens S.L., King J.S., Simon R.P. Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke 2007, 38:680-685.
53. Tao J., Wu H., Lin Q., Wei W., Lu X.H., Cantle J.P., Ao Y., Olsen R.W., Yang X.W., Mody I., Sofroniew M.V., Sun Y.E. Deletion of astroglial dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J. Neurosci. 2011, 31:8306-8319.
54. Urdinguio R.G., Sanchez-Mut J.V., Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol. 2009, 8:1056-1072.
55. Wayman G.A., Davare M., Ando H., Fortin D., Varlamova O., Cheng H.Y., Marks D., Obrietan K., Soderling T.R., Goodman R.H., Impey S. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9093-9098.